Satisfaction with treatment among patients with psoriasis: A web-based survey study

British Journal of Dermatology

Volumn 169, Issue 2, 2013, Pages 398-405

  Van Cranenburgh, O D ^a   De Korte, J ^a   Sprangers, M A G ^a   De Rie, M A ^a   Smets, E M A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; DERMATOLOGICAL AGENT;

ARTICLE; DEMOGRAPHY; DOCTOR PATIENT RELATION; DRUG SAFETY; FEMALE; GUTTATE PSORIASIS; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; BIOLOGICAL FACTORS; COMMUNICATION; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; FEMALE; HEALTH SURVEYS; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PHOTOTHERAPY; PHYSICIAN-PATIENT RELATIONS; PSORIASIS; TREATMENT OUTCOME;

EID: 84881564770     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12372     Document Type: Article

References (38)

1. de Korte J, Sprangers MA, Mombers FM, et al,. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol Symp Proc 2004; 9: 140-7.
2. Rapp SR, Feldman SR, Exum ML, et al,. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-7.
3. Schafer I, Hacker J, Rustenbach SJ, et al,. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol 2010; 20: 62-7.
4. Food and Drug Administration. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD: FDA, 2009.
5. Renzi C, Tabolli S, Picardi A, et al,. Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol 2005; 19: 712-18.
6. Barbosa CD, Balp MM, Kulich K, et al,. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence 2012; 6: 39-48.
7. Finlay AY, Ortonne JP,. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J Cutan Med Surg 2004; 8: 310-20.
8. Renzi C, Abeni D, Picardi A, et al,. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001; 145: 617-23.
9. Augustin M, Holland B, Dartsch D, et al,. Adherence in the treatment of psoriasis: a systematic review. Dermatology 2011; 222: 363-74.
10. Bewley A, Page B,. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 2011; 25 (Suppl. 4): 9-14.
11. Richards HL, Fortune DG, Griffiths CE,. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 370-9.
12. Leung YY, Tam LS, Lee KW, et al,. Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis. Rheumatology (Oxford) 2009; 48: 53-6.
13. van Campen C, Sixma H, Friele RD, et al,. Quality of care and patient satisfaction: a review of measuring instruments. Med Care Res Rev 1995; 52: 109-33.
14. Williams B,. Patient satisfaction: a valid concept? Soc Sci Med 1994; 38: 509-16.
15. Lecluse LL, Tutein Nolthenius JL, Bos JD, et al,. Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol 2009; 160: 1340-3.
16. Shikiar R, Rentz AM,. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7: 204-15.
17. Krueger G, Koo J, Lebwohl M, et al,. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-4.
18. Sandelowski M, Barroso J,. Handbook for Synthesizing Qualitative Research. New York, NY: Springer Publishing Company USA, 2007.
19. Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV). Kwaliteitsinstituut voor de Gezondheidszorg CBO. Richtlijn: Foto(chemo)therapie en systemische therapie bij ernstige chronische plaque psoriasis. Utrecht: NVDV, 2005.
20. Sixma HJ, Kerssens JJ, Campen CV, et al,. Quality of care from the patients' perspective: from theoretical concept to a new measuring instrument. Health Expect 1998; 1: 82-95.
21. Christophers E, Griffiths CE, Gaitanis G, et al,. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review. J Eur Acad Dermatol Venereol 2006; 20: 921-5.
22. Dubertret L, Mrowietz U, Ranki A, et al,. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-36.
23. Stern RS, Nijsten T, Feldman SR, et al,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004; 9: 136-9.
24. Nijsten T, Margolis DJ, Feldman SR, et al,. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005; 52: 434-44.
25. Hjortsberg C, Bergman A, Bjarnason A, et al,. Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol 2011; 91: 409-14.
26. Jones-Caballero M, Unaeze J, Penas PF, et al,. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective. Arch Dermatol 2007; 143: 846-50.
27. Wu Y, Mills D, Barrett J, et al,. Poor patient satisfaction and medication adherence among patients with psoriasis: results from a large national survey. Psoriasis Forum 2007; 13: 22-6.
28. Tennvall GR, Hjortsberg C, Bjarnason A, et al,. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol 2013; 93: 442-5.
29. Atkinson MJ, Sinha A, Hass SL, et al,. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2: 12.
30. Renzi C, Di Pietro C, Tabolli S,. Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol 2011; 36: 885-8.
31. Linder D, Dall'olio E, Gisondi P, et al,. Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study. Am J Clin Dermatol 2009; 10: 325-30.
32. Maguire P, Pitceathly C,. Key communication skills and how to acquire them. BMJ 2002; 325: 697-700.
33. van de Kerkhof PC, de Hoop D, de Korte J, et al,. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000; 200: 292-8.
34. Langenbruch AK, Schafer I, Franzke N, et al,. Internet-supported gathering of treatment data and patient benefits in psoriasis. J Eur Acad Dermatol Venereol 2010; 24: 541-7.
35. Umar N, Yamamoto S, Loerbroks A, et al,. Elicitation and use of patients' preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol 2012; 92: 341-6.
36. Glenn C, McMichael A, Feldman SR,. Measuring patient satisfaction changes patient satisfaction. J Dermatol Treat 2012; 23: 81-2.
37. Sackett DL, Straus SE, Richardson WS, et al,. Evidence-Based Medicine: How to Practice and Teach EBM, 2nd edn. London: Churchill Livingstone, 2000.
38. Spuls PI, Nast A,. Evaluation of and perspectives on guidelines: what is important? J Invest Dermatol 2010; 130: 2348-9.